神经生长因子基因多态可能与女性的海洛因依赖有关,但不会调解特定的人格特征
Shin-Chang Kuo1, Chun-Long Lin2,3, Chang-Chih Tsou1
1Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
European archives of psychiatry and clinical neuroscience
|September 23, 2024
概括
神经生长因子 (NGF) 基因的遗传变异可能会增加女性的海洛因依赖 (HD) 风险. 然而,这些NGF基因多态性似乎不会影响HD患者的冲动性或个性特征.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 精神病学是一个精神病学.
背景情况:
- 海洛因依赖 (HD) 是一种复杂的疾病,具有重要的遗传基础.
- 神经生长因子 (NGF) 与HD相关的奖励途径有关.
- 冲动性和个性特征经常在患有HD的个体中观察到.
研究的目的:
- 调查NGF基因多态性和HD与冲动性和个性特征的同时发生之间的关联.
- 探索潜在的性别特异性遗传影响在HD和相关的行为特征.
主要方法:
- 研究了一组1364名汉族参与者 (831名HD患者,533名对照).
- 对NGF基因多态性进行了基因定型,并分析了等位基因和基因型频率.
- 冲动性 (BIS-11) 和人格特征 (TPQ) 在HD患者的小组中进行了评估.
主要成果:
- 三种特定的NGF多态 (rs2254527,rs6678788,rs7523654) 显示了HD患者和对照人群,特别是女性之间的等位基因/基因型频率的显著差异.
- 哈普洛型分析显示,女性子组中存在显著的关联,但男性中没有.
- 在研究的NGF多态性和HD患者的冲动性或人格特征得分之间没有发现显著的关联.
结论:
- NGF基因变异可能导致海洛因依赖的易感性,特别是在女性中.
- 研究的NGF多态性似乎没有调解研究人口中冲动性/个性特征和HD之间的关系.
更多相关视频
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.2K
04:11A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
16.9K
相关概念视频
Human Genetics
542
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
542
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Single Nucleotide Polymorphisms-SNPs
14.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K
Analgesia and Pain Management
551
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
